Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06701084 · ClinicalTrials.gov registry record · NA
Molecular Genetic Mechanisms of Infantile Epilepsies and the Impact of Genetic Diagnosis
A NA study of Neonatal Epilepsy and Infantile Epilepsy, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT06701084 is a NA study of Neonatal Epilepsy and Infantile Epilepsy that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 600 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06701084, a NA study of Neonatal Epilepsy and Infantile Epilepsy, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to discover new genetic causes of infantile epilepsies and evaluate the impact of these discoveries on infants with epilepsy and their families.
Conditions Studied
Interventions
- GENETIC Genomic Sequencing
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2021-09-02 |
| Est. Completion | 2029-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06701084
The ClinicalTrials.gov registry entry for NCT06701084 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Neonatal Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Genomic Sequencing is the first listed.
NCT06701084 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06701084 about?
NCT06701084 is a clinical study titled "Molecular Genetic Mechanisms of Infantile Epilepsies and the Impact of Genetic Diagnosis". The goal of this study is to discover new genetic causes of infantile epilepsies and evaluate the impact of these discoveries on infants with epilepsy and their families.
What is the current status of trial NCT06701084?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2021-09-02. Estimated completion is 2029-11.
What conditions does trial NCT06701084 study?
This clinical trial studies the following conditions: Neonatal Epilepsy, Infantile Epilepsy.
What interventions are being tested in trial NCT06701084?
The interventions under investigation include: Genomic Sequencing (GENETIC).
Who is sponsoring clinical trial NCT06701084?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06701084 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.